Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

AstraZeneca's Nexium for erosive esophagitis launched in U.S.

March 23, 2001

Adolor's opioid gastrointestinal drug enters late-stage clinical development

March 22, 2001

Isis and Merck & Co. extend HCV collaboration

March 21, 2001

New agents for HCV infection patented by DuPont scientists

March 20, 2001

Gastrointestinal and colonic prokinetic effects of prucalopride confirmed in constipated patients

March 15, 2001

Inhibition of iNOS as a therapeutic approach to inflammatory bowel disease

March 13, 2001

Targacept and Dr. Falk to develop novel ulcerative colitis therapy

March 12, 2001

Chiron grants Japan Tobacco license to HCV drug target

March 9, 2001

StemCells receives SBIR grant for liver disease research

March 7, 2001

Anti-H. pylori dioxopiperazines discovered at Yamanouchi

March 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 24, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026